Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 14/20 | 1.00 |
| ▸ | NOS1 | P29475 | 4/20 | 1.00 |
| ▸ | NOS3 | P29474 | 1/20 | 1.00 |
| ▸ | NOS2 | P35228 | 1/20 | 1.00 |
| ▸ | SLC11A2 | P49281 | 1/20 | 0.76 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzyl Carbamimidothioate SCHEMBL893859 | 0.98 | IDO1 (1.00) | IDO1NOS1NOS3NOS2SLC11A2 | |
| Benzyl Carbamimidothioate SCHEMBL28084166 | 0.98 | IDO1 (0.95) | IDO1NOS1NOS3NOS2SLC11A2 | |
| Benzyl Carbamimidothioate SCHEMBL14576763 | 0.98 | IDO1 (1.00) | IDO1NOS1NOS3NOS2SLC11A2 | |
| Benzyl Carbamimidothioate SCHEMBL4911682 | 0.98 | IDO1 (1.00) | IDO1NOS1NOS3NOS2SLC11A2 | |
| Benzyl Carbamimidothioate SCHEMBL28084165 | 0.96 | IDO1 (0.91) | IDO1NOS1NOS3NOS2SLC11A2 | |
| Benzyl Carbamimidothioate SCHEMBL27962431 | 0.96 | IDO1 (0.91) | IDO1NOS1NOS3NOS2SLC11A2 | |
| Benzyl Carbamimidothioate SCHEMBL9507886 | 0.94 | IDO1 (0.88) | IDO1NOS1NOS3NOS2SLC11A2 | |
| Benzyl Carbamimidothioate SCHEMBL27476627 | 0.92 | IDO1 (0.84) | IDO1NOS1NOS3NOS2SLC11A2 | |
| Benzyl Carbamimidothioate SCHEMBL14714919 | 0.90 | IDO1 (0.81) | IDO1NOS1NOS3NOS2SLC11A2 | |
| Benzyl Carbamimidothioate SCHEMBL11527781 | 0.90 | IDO1 (0.81) | IDO1NOS1NOS3NOS2SLC11A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 350 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3473710-B1 | SACCHARIFICATION REACTION SOLUTION, SACCHARIFYING ENZYME COMPOSITION, SUGAR PRODUCTION METHOD, AND ETHANOL PRODUCTION METHOD | NISSAN CHEMICAL CORP (JP) | 2023-09-27 | — | — | EP | claimed |
| CN-109312318-B | Saccharification reaction liquid, saccharifying enzyme composition, method for producing sugar, and method for producing ethanol | 日产化学株式会社 | 2022-06-03 | — | — | CN | claimed |
| US-20190300921-A1 | SACCHARIFICATION REACTION MIXTURE, SACCHARIFICATION ENZYME COMPOSITION, SUGAR PRODUCTION METHOD, AND ETHANOL PRODUCTION METHOD | NISSAN CHEMICAL CORPORATION (JP) | 2019-10-03 | — | — | US | claimed |
| EP-3473710-A1 | SACCHARIFICATION REACTION SOLUTION, SACCHARIFYING ENZYME COMPOSITION, SUGAR PRODUCTION METHOD, AND ETHANOL PRODUCTION METHOD | Nissan Chemical Corporation (JP) | 2019-04-24 | — | — | EP | claimed |
| CN-106084714-A | A kind of agricultural mulching and preparation method thereof | 吉林省农业科学院 | 2016-11-09 | — | — | CN | claimed |
| US-20140221658-A1 | INHIBITION OF CELL PROLIFERATION | UNIVERSITY OF SOUTH FLORIDA (US) | 2014-08-07 | — | — | US | claimed |
| US-8642278-B2 | Inhibition of cell proliferation | UNIVERSITY OF SOUTH FLORIDA (US) | 2014-02-04 | — | — | US | claimed |
| WO-2012063115-A2 | PROCESS FOR THE PREPARATION OF ROSUVASTATIN CALCIUM VIA NOVEL AMINE INTERMEDIATE | JUBILANT LIFE SCIENCES LTD. (IN) | 2012-05-18 | — | — | WO | claimed |
| US-20110190125-A1 | 2-(BENZYLSULFONYL)OXAZOLE DERIVATIVES, CHIRAL 2-(BENZYLSULFINYL)OXAZOLE DERIVATIVES... | BAYER CROPSCIENCE AG (DE) | 2011-08-04 | — | — | US | claimed |
| EP-1962892-A2 | INHIBITION OF CELL PROLIFERATION | University of South Florida (US) | 2008-09-03 | — | — | EP | claimed |
| EP-1280526-A1 | COMPOSITION FOR THE PREVENTION AND/OR TREATMENT, IN NEWBORN BABIES, OF THE EFFECTS OF COMPLICATIONS DURING CHILDBIRTH | Universitair Medisch Centrum Utrecht (NL) | 2003-02-05 | — | — | EP | claimed |
| US-20030004340-A1 | New 4-arylpiperidine derivatives for the treatment of pruritus | GIBSON STEPHEN PAUL (GB) | 2003-01-02 | — | — | US | claimed |
| WO-2001074351-A1 | COMPOSITION FOR THE PREVENTION AND/OR TREATMENT, IN NEWBORN BABIES, OF THE EFFECTS OF COMPLICATIONS DURING CHILDBIRTH | UNIVERSITAIR MEDISCH CENTRUM (NL) | 2001-10-11 | — | — | WO | claimed |
| EP-1072601-A2 | 4-arylpiperidine derivatives for the treatment of pruritus | PFIZER INC. (US) | 2001-01-31 | — | — | EP | claimed |
| EP-0670720-A1 | ENZYME INHIBITORS | THE WELLCOME FOUNDATION LIMITED (GB) | 1995-09-13 | — | — | EP | claimed |
| CN-1095710-A | Enzyme Inhibitors | WELLCOME FOUND (GB) | 1994-11-30 | — | — | CN | claimed |
| WO-1994012165-A2 | ENZYME INHIBITORS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-06-09 | — | — | WO | claimed |
| US-4587296-A | IMPROVED RETENTION OF PHYSICAL PROPERTIES | MONSANTO EUROPE, S.A. (BE) | 1986-05-06 | — | — | US | claimed |
| EP-0070143-B1 | ORGANIC THIOSULPHATES AND THIOSULPHONATES USEFUL AS STABILISING AGENTS FOR RUBBER VULCANISATES | MONSANTO EUROPE S.A./N.V. (BE) | 1985-02-20 | — | — | EP | claimed |
| EP-0070143-A1 | Organic thiosulphates and thiosulphonates useful as stabilising agents for rubber vulcanisates | MONSANTO EUROPE S.A./N.V. (BE) | 1983-01-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190125-A1 | 2-(BENZYLSULFONYL)OXAZOLE DERIVATIVES, CHIRAL 2-(BENZYLSULFINYL)OXAZOLE DERIVATIVES... | BBOX1, STS, OXA1L | IDO1 395/4885NOS1 931/4885NOS3 763/4885 |
| US-20030004340-A1 | New 4-arylpiperidine derivatives for the treatment of pruritus | HRH2, HRH4, HRH1 | IDO1 230/4885NOS1 1525/4885NOS3 2250/4885 |
| US-20140221658-A1 | INHIBITION OF CELL PROLIFERATION | RB1, RAF1, NRAS | IDO1 4187/4885NOS1 3526/4885NOS3 3705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.